Michael Gelband’s HUMANIGEN, INC. HGEN Stock Holding History

Michael Gelband’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-31,100	Closed	-$545K	–	2740
2020 Q4	$545K	Buy	+31,100	New	+$372K	0.01%	1194

Other funds holding HGEN

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Michael Gelband's HGEN Position: Q3 2022 in Review

Michael Gelband sold out of HUMANIGEN, INC. (HGEN) in Q3 2022, closing a stake of 32,171 shares — an estimated $57K sold.

Michael Gelband first reported a position in HGEN in Q3 2020 and held it in 6 quarters. The position peaked at $2.2M in Q4 2020. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.

Michael Gelband reported no remaining HUMANIGEN, INC. position as of Q3 2022 after selling out during the quarter.
Michael Gelband sold 32,171 HUMANIGEN, INC. shares in Q3 2022, an estimated $57K.
Michael Gelband first reported a position in HUMANIGEN, INC. in Q3 2020 and held it in 6 quarters.
Michael Gelband's HUMANIGEN, INC. position peaked at $2.2M in Q4 2020.
53 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2022.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.